Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

BACKGROUND: After successful of antiretroviral therapy, highly effective direct acting antiviral (DAA) make HCV elimination reasonable in HIV/HCV co-infected patients. However, in achieving this target, there are still barriers to start DAA treatment, particularly in the area of liver fibrosis asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Yunihastuti, Evy, Wicaksana, Bramantya, Wiraguna, Andrian, Hidayah, Ainum Jhariah, Amelia, Fhadilla, Natali, Veritea, Widhani, Alvina, Sulaiman, Andri Sanityoso, Kurniawan, Juferdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249442/
https://www.ncbi.nlm.nih.gov/pubmed/32450844
http://dx.doi.org/10.1186/s12879-020-05069-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249442/
https://www.ncbi.nlm.nih.gov/pubmed/32450844
http://dx.doi.org/10.1186/s12879-020-05069-5

Ejemplares similares